Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Cited by
135 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of Urate-Lowering Therapy on Cardiovascular and Kidney Outcomes;Clinical Journal of the American Society of Nephrology;2020-10-14
2. Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemia;Journal of Cardiology;2017-01
3. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia;International Journal of Rheumatic Diseases;2014-01-28
4. Multicenter, Open-Label Study of Long-Term Administration of Febuxostat (TMX-67) in Japanese Patients With Hyperuricemia Including Gout;JCR: Journal of Clinical Rheumatology;2011-06
5. An Allopurinol-Controlled, Multicenter, Randomized, Open-Label, Parallel Between-Group, Comparative Study of Febuxostat (TMX-67), a Non-Purine-Selective Inhibitor of Xanthine Oxidase, in Patients With Hyperuricemia Including Those With Gout in Japan;JCR: Journal of Clinical Rheumatology;2011-06